Early Access — free while we kick the tires
EdgarHawk

Lizardi Rafael R

Sr. Vice President & CFO

Officer

Latest: Sr. Vice President & CFO selling · April 2026

4 filings analyzed · 1 company · Latest 2026-05-15

Companies

Company Buys Sells Direction
TEXAS INSTRUMENTS INC TXN 0 15 Net selling

Activity

May 2026
high
Sell
47,734 shares
$14,706,996
Significance 6/10

TXN CFO Lizardi sells 3 tranches totaling 47,734 shares for $14.7M near 52-week high (-0.4%), reducing holdings by -35.8%

Rafael R Lizardi, Sr. Vice President & CFO of Texas Instruments Inc, filed 3 separate sales totaling 47,734 shares for $14,706,996.48, executed at prices of $307.85, $308.54, and $309.45 on 2026-05-14. The transactions reduce his holdings from 133,219 shares to 85,485 shares, a -35.8% reduction, and were executed with the stock sitting just -0.4% from its 52-week high of $309.32 following a 30-day gain of +40.8%. His 5 prior trades at TXN all posted positive 90-day returns ranging from +11.8% to +35.0%, with 0 of 5 prior sells at this ticker having generated a negative 90-day return — meaning the stock rose after each of those sales. His cross-ticker track record across 7 prior sells shows an avg 90-day return of +16.8% and a 90-day well-timed rate of 14.29%, indicating that across all tickers, prior sells have generally not been followed by stock declines.

April 2026
medium
Sell
40,541 shares
$11,117,556
Significance 7/10

C-suite executive at Texas Instruments buys large stake while multiple insiders simultaneously divest significant holdings.

One executive accumulated a substantial position in Texas Instruments on the same day that multiple other insiders sold significant portions of their holdings, creating a mixed signal about management confidence. The buyer is purchasing into a company with strong profitability and solid revenue growth, though the stock is trading near its recent highs after a sharp recovery in recent weeks. The simultaneous sales by other executives—totaling over six million dollars—suggest possible portfolio rebalancing or tax-motivated selling rather than a unified bearish view, yet the divergence warrants attention. The buyer's conviction to deploy significant capital into a profitable, growing semiconductor company with solid fundamentals could indicate selective buying opportunity, but the coordinated selling by peers on the same date raises questions about timing and messaging clarity.

February 2026
high
Sell
71,628 shares
$15,882,150
Significance 6/10

TXN CFO Lizardi sells 71,628 shares for $15.9M across 3 trades; holdings down 45.6% to 85.5K shares

Lizardi Rafael R, Sr. Vice President & CFO of Texas Instruments, executed 3 separate sales totaling 71,628 shares (71.6K shares) for $15,882,149.97 ($15.9M) at a blended average price of $221.73 on 2026-02-10 and 2026-02-11. His post-transaction holdings of 85,454 shares (85.5K shares) represent a -45.6% reduction from pre-transaction holdings of 157,082 shares (157.1K shares), a material reduction in his equity stake. At $223.00 current price, the sale occurred near the 52-week high ($226.56, -1.6% below peak) and follows a strong 30-day (+18.3%) and 90-day (+40.0%) rally; his prior TXN sell on 2024-11-07 showed 90d return of -16.4%, falling into his cross-ticker track record pattern where 100.00% of his prior sells were well-timed at the 90-day horizon. The company's fundamentals remain robust (annual revenue growth +13.0%, P/E 38.58, market cap $202.4B), providing no visible operational distress to explain the sale.

November 2024
medium
Sell
46,917 shares
$10,188,294
Significance 5/10

CFO Rafael Lizardi sells 46.9K TXN shares at $217.16 for $10.2M, reduces holdings 38.8%

Rafael Lizardi, Sr. Vice President & CFO of Texas Instruments, sold 46,917 shares at $217.16 on 2024-11-07, reducing his holdings from 120,978 to 74,061 shares (a -38.8% reduction). The sale occurred near the company's 52-week high of $220.29, with TXN's current price at $205.72 reflecting a -6.6% pullback from that peak and -1.4% over the prior 30 days. This represents a substantial reduction in the CFO's personal stake during a period when the company is navigating a challenging revenue environment: full-year revenue growth stands at -12.5% against the prior year, despite recent quarterly revenue of $4.2B and net income of $1.4B. The magnitude and timing of this divestiture warrant monitoring in the context of Texas Instruments' cyclical positioning and the CFO's reduced financial exposure to future performance.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access